Press Releases

In case you missed it – Representative Mariannette Miller-Meeks (IA-01) has recently been appointed to several leadership positions in the new Congress including a seat on the House Committee on Energy and Commerce, the Select Subcommittee on the Coronavirus Pandemic, and a Chair position on the House Committee on Veterans’ Affairs Health Subcommittee.

WASHINGTON, D.C. – Representative Mariannette Miller-Meeks today issued the following statement regarding her appointment to the House Committee on Energy and Commerce:

WASHINGTON, D.C. – Representative Mariannette Miller-Meeks today issued the following statement after Representative Kevin McCarthy was elected to serve as Speaker of the House of Representatives:

WASHINGTON, D.C. – Representative Mariannette Miller-Meeks (IA-02) today was joined by Representatives Randy Feenstra (IA-04), Ashley Hinson (IA-01), and Cindy Axne (IA-03) in a letter to United States Trade Representative Ambassador Katherine Tai demanding action be taken to enforce the United States-Mexico-Canada Agreement (US

WASHINGTON – Rep. Mariannette Miller-Meeks (R-Iowa) and Sen.

WASHINGTON, D.C. – Representative Mariannette Miller-Meeks (IA-02) and House Committee on Natural Resources Ranking Member Bruce Westerman (AR-04) today introduced the Stay Off My Line Act, legislation to support much needed transmission projects by clarifying how projects are classified under the National Environmental Policy A

WASHINGTON, D.C. – Representatives Mariannette Miller-Meeks (IA-02), Brian Fitzpatrick (PA-01), Bob Gibbs (OH-07), and Richard Hudson (NC-08) today introduced the Know Before You Owe Federal Student Loan Act, legislation that would require Institutes of Higher Education (IHEs) to counsel students before any federal loans are dis

WASHINGTON, D.C. – Representatives Mariannette Miller-Meeks (IA-02), Greg Murphy (NC-03), Nanette Barragán (CA-44), and Ann Kuster (D-NH) today introduced the Biologics Competition Act, legislation to direct the Secretary of Health and Human Services to evaluate the process by which interchangeable biological products are approv